CClinicalTrials.gg
Active, not recruitingNCT06140277Updated Nov 18, 2023

Using Of Chitosan in Alveolar Ridge Preservation

A Phase 2 interventional study of extraction with chitosan particles as a replacement for bone graft with collagen membrane and extraction with placing of allograft particles with collagen membrane in Tooth Extraction Status Nos and Bone Augmentation, sponsored by Prince Sattam Bin Abdulaziz University. Active, not recruiting at 1 site in Saudi Arabia. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Prince Sattam Bin Abdulaziz University · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as active, not recruiting.
  • Registered 5 months after the study started (first participant enrolled Jan 2023, registered Jul 2023).
Phase
Phase 2
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this clinical trial is to assess the efficacy of chitosan as a socket preservation material after tooth extraction in compare to the standard treatment. The study will include patients who exhibit hopeless tooth without any periodontal infection. Smokers, history of allergy, patients with major medical issue and pregnant women will be excluded from the study. The main question[s] to answer is : is there a significant difference in bone density and dimension between the test and control groups after tooth extraction or not.

Participants will be asked to do CBCT scan and take upper and lower impressions before extraction and after three month from extraction. Then, the patients will randomly assigned to one from these groups: There will be a total of three groups (10 patients for each), first group will be treated using mixed of chitosan and allograft, second group will be treated using allograft alone and the last group will be used as control. All patients will be treated in accordance with the 2013 Declaration of Helsinki.

Read the detailed description

To evaluate the tissue response, intraoral impressions and X-ray will be taking from each patient before extraction and three months after. Also, Cone-beam computed tomography (CBCT) will be taking to measure the bone growth at base line and three months after surgery is done. For measurement, each socket will be vertically divided into 3 equal areas: coronal, middle, and apical. Regenerated bone density will be assessed in each area, in both control and intervention groups.

Data then can be analyzed using SPSS ver. 11 (SPSS Inc., Chicago,USA). P-values less than 0.05 were considered as significant.

02

Conditions studied

  • Tooth Extraction Status Nos
  • Bone Augmentation

Keywords

  • chitosan
  • socket preservation
03

In context

Lead sponsor

Prince Sattam Bin Abdulaziz University is the lead sponsor of 34 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Clinical diagnosis of hopeless tooth.
  • Healthy patient.
  • Healthy gingiva without any periodontal disease.
  • Patient is welling to come after three months.

Exclusion criteria

Exclusion Criteria:

  • Smokers.
  • History of allergy.
  • pregnant women.
  • patient with systemic disease.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Chitosan

    group will be treated using chitosan as a replacement of bone particles with collagen membrane after tooth extraction

    Procedure: extraction with chitosan particles as a replacement for bone graft with collagen membrane

  • Active comparator
    Allograft

    after extraction, the group will be treated using the gold standard protocol which is the (allograft) bone particles with collagen membrane.

    Procedure: extraction with placing of allograft particles with collagen membrane

  • Placebo comparator
    placebo

    the extraction will be done without placing any bone material inside

    Procedure: tooth extraction only

Interventions

  • Procedureextraction with chitosan particles as a replacement for bone graft with collagen membrane

    to replace the bone at the extraction site we will put either chitosan or allograft particles

    Also known as: chitosan

  • Procedureextraction with placing of allograft particles with collagen membrane

    to replace the bone at the extraction site we will put allograft particles

    Also known as: gold standard treatment

  • Proceduretooth extraction only

    hopeless tooth will be extracted without any intervention

    Also known as: normal extraction

06

What researchers measure

Primary outcomes

  1. Bone Hight

    Changes in vertical dimension in mm from baseline using scans section from CBCT.

    Time frame: 3 months

  2. Bone volume

    Changes in horizontal width in mm from baseline using scans section from CBCT.

    Time frame: 3 months

Secondary outcomes

  1. Tissue healing

    changes in scale of redness of gingiva from baseline

    Time frame: 3 months

  2. Dry socket

    the No of exposed bone from baseline until healing

    Time frame: 3 months

07

Study locations

1 site
  • Prince Sattam Bin Abdulaziz University
    Riyadh, Central 16273, Saudi Arabia
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06140277
Lead sponsor
Prince Sattam Bin Abdulaziz University
Responsible party
Sponsor
First posted
Nov 18, 2023
Start date
Jan 18, 2023
Primary completion
Dec 1, 2023 (estimated)
Completion
Mar 20, 2024 (estimated)
Last update
Nov 18, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion